Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-015794

President and CEO acquired 132,679 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Walker Neal President and CEO 2022-03-01 Option exercise +96,150 1,335,537 D
Walker Neal President and CEO 2022-03-01 Option exercise +18,275 1,353,812 D
Walker Neal President and CEO 2022-03-02 Option exercise +18,254 1,372,066 D
Derivatives
Walker Neal President and CEO 2022-03-01 Grant or award · Employee Stock Option (Right to Buy) +336,100 336,100 D
Walker Neal President and CEO 2022-03-01 Grant or award · Restricted stock units +96,000 96,000 D
Walker Neal President and CEO 2022-03-01 Option exercise · Restricted stock units −96,150 96,150 D
Walker Neal President and CEO 2022-03-01 Option exercise · Restricted stock units −18,275 54,825 D
Walker Neal President and CEO 2022-03-02 Option exercise · Restricted stock units −18,254 36,508 D
Loading xslF345X03/doc4.xml…